Concepedia

Francisco M. Marty

FM

Statistics

Publications

144

Citations

17.6K

H-Index

63

Active since

2001

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Dana-Farber Brigham Cancer Center

Fred Hutch Cancer Center

Francisco M. Marty is an author at Brigham and Women's Hospital specializing in infectious diseases, medicine, and transplant immunology.

ORCID

Publications per year

2001–2023

144

Publications

144

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

, , +16

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

Robert Gottlieb, Carlos Vaca, Roger Paredes et al. · New England Journal of Medicine · 2021 · 1.3K citations · Full text

, , +13

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

, , +9

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

, , +17

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 694 citations

, , +15

1–5 of 144